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Peripheral blood mononuclear leukocytes (MNL) from 
patients with atopic dermatitis spontaneously produce 
large amounts of lgE in vitro. These cells also show 
mar kedly elevated levels of cAMP phosphodiesterase 
(PDE ) which may be responsible for the observed ab-
normal cAMP r esponsiveness. Treatment of atopic der-
matitis MNL with varying concentrations of the cAMP 
PDE inhibitor Ro 20-1724 resulted in progressively 
decreasing amounts of lgE synthesis, statistically sig-
nificant at the 10_,, M and 10-5 M concentrations. There 
was a close correlation between PDE inhibition and 
inhibition of lgE synthesis, r = 0.93, p < 0.05 . To define 
the cellular target of the drug, we used monoclonal 
antibodies directed toward MNL subsets (Lyt 3, OKTS, 
O K T 4 , monocyte-myeloid) in a modified "panning" 
method to perform experiments with purified subsets. 
With untreated subsets, removal of OKT4-positive cells 
s ignificantly reduced lgE sy nthesis; ~eaddition of 
OKT4-positive cells enhanced IgE sy nthesis. OKT8 cells 
and monocytes did not affect lgE synthesis. Pretreat-
m ent ofT cell -depleted MNL with Ro 20-1724 resulted 
in significantly more inhibition of lgE synthesis than 
did pre treatment of T enriched cells prior to recombi-
nat ion with the reciprocal untreated subset and subse-
q uen t culture. Similarly, pretreatment of rr.'on?c?'~e-de­
pleted ce lls resulted in significantly more mhiblti~:m of 
IgE s ynthesis tha n pretreatment of monocyte-enriched 
c e lls prior to recombination and culture. The majority 
of t h e effect appeared to be mediated by a direct effect 
on t h e B ce lls . However, some inhibit ion of lgE sy nthesis 
was a lso achieved through pre treatment of T enriched 
cells. Since pretreatment of isolated suppressor/cy to-
t o x ic or helper/ inducer T-cell subse ts did not give the 
same degree of inhibition as with unfractionated T cells , 
a T-T interaction may be involved in this aspect. 
The imidazolidinone derivative, Ro 20-1724 , signifi-
cantly and consistently inhibited both the elevated 
c AMP phophodiesterase activity and the e leva ted spon-
tane ous l gE synthesis of MNL from patients with atopic 
d e r m atitis . These findings de monstra te a previously un-
d escribed link be tween cAMP P DE leve ls and in vitro 
IgE s y nthesis . 
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Patients wit h atopic dermatit is (AD ), a disease characterized 
by high t issue histam ine levels [1,2], demonstrate a variety of 
immunologic and pharmacologic abnormali t ies. We have shown 
t hat blood leukocytes from patients wi t h AD show markedly 
reduced cAMP responses to isoproterenol, histamine, and pros-
taglandin E 1 (PGE1 ) [3). Simila rly reduced responses were 
observed in normal leukocytes desensit ized by micromola r con-
centrations of histamine [3,4]. 
It. appears that this lack of cAMP responsiveness is due to 
rapid hydrolysis of cAMP by increased in t racellula r cAMP 
phosphodiesterase (PDE) as evidenced by our findings t hat 
cell s from patients wit h AD, as well as normal cells exposed to 
low concent rat ions of histamine, have a dramatic and consist-
ent elevat ion of a high-act ivity form of PDE [4,5]. Increased 
leukocyte cAMP PDE and consequent lack of cAMP-mediated 
immunoregulatory influences may provide a permissive effect 
on leukocyte functions such as lgE production [6] and hista-
mine release [7). 
P atients wi t h AD have elevated serum IgE levels [6] and this 
is reflected in t he findin g that AD leukocytes placed in cul ture 
spontaneously produce elevated levels of IgE over a 7- to 10-
day culture period [8- 11) . While largely independent of radi -
oresistant T -cell help [9,11], the IgE-producing B cells a re 
sensit ive to suppression by high numbers of added allogeneic 
norma l T cells. Although purely a llogeneic effects were not 
excluded in a ll t hese studies [8,12,13], others have excluded 
t his mechanism [9] . Several of t hese studies revealed a lack of 
T suppressor activi ty by cells from AD or hyperimmunoglobu-
linemia E syndrome pat ients but t hese fi ndings have not been 
consistent, and some patients, whose mononuclear leukocytes 
(M NL) overproduce IgE, clearly have normal T suppressor 
function [8,9,11,12]. A recent study showed t hat T -cell super-
natants from patients wit h AD enhanced IgE synt hesis by B 
cells [1 4). The complete role of T lymphocytes in elevated lgE 
product ion by cells from patients wi t h hyperimmunoglobuli-
nemia E states remains uncerta in. 
The purpose of t his study was to determine the effect upon 
in vit ro l gE synthesis by leukocytes from patients with AD 
when t he elevated PDE activity was lowered by t he PDE 
inhibi tor Ro 20- 1724 (d,l-1 ,4- [3-butoxy-4-methoxybenzyl)-2-
imidazolidinone). Using a modification of t he "pan ning" 
method for sort ing leukocytes with monoclonal ant ibodies [15-
19], t he leukocyte subsets affected by t he drug were ident ified. 
MATERIALS AND MET HODS 
Experimental Subjects 
Normal, nonatopic adult volunteers and adult atopic patients, ages 
18- 50 years, were phlebotomized between 8:00 and 10:00 AM after 
overnight avoidance of coffee and other PDE inhibitor-containing 
beverages. Therapeutic agents such as antihistamines and topical ste-
roids were discontinued at least 48 h prior to the study. Systemic 
corticoste roids and theophyll ine were discontinued at least 2 weeks 
prior to study. All patients had asthma and/or allergic rhin itis in 
addition to AD. 
In Vitro lgE Production 
To study the in vitro effect of Ro 20·1724 on lgE production, MNL 
were separated from heparinized venous blood by Ficoll ·Hypaque gra · 
d.ient centrifugation, washed 3 times in saline, and resuspended in 
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RPM! 1640 (Gibco, Grand Island, New York). For spontaneous lgE 
production in vitro, cells were adjusted to 1.5 x 106/ ml in RPM! 1640 
supplemented with 10% feta l calf se rum (FCS), 2 mM glutamine, 
penicillin 100 U/ml , streptomycin 100 ,ug/ ml , and amphote ricin B 0.25 
mg/m l. The ce ll suspens ion (tota l vo lume, 1.5 ml) was incubated in 12 
x 75 mm polystyrene tubes (Falcon 2054) in a 5% C02 humidified 
atmosphere at 37"C for 10 days. The ce lls were subjected to 5 cycles of 
freeze-thaw and held in culture for 3 more days to a llow microsomal 
release of all immunoreactive lgE. Culture supernatants were harvested 
on clay 13 by centrifugation at 500 g for 10 min and stored at - 2o•c 
un t il assayed. To determine preform ed lgE, controls were incubated 
with cyclohex imide 500 g/ml for 10 clays or subjected to freezing and 
t hawi ng 5 t imes on clay 0 [8]. Preformed lgE levels did not significantly 
di ffe r between these methods. (Cyclohex imide method: 606 ± 285 pg/ 
ml preformed lgE vs freeze and thaw method: 767 ± 468 pg/ ml , n = 5 
paired comparisons.) 
For dete rmination of t he Ro 20-1724 close response on lgE production 
in vitro, cells were adjusted to 1.5 X 106/ ml in 1.5 ml RPM ! 1640 
supplemented with 2 mM glu tamine and antibiotics as ment ioned above 
(2.25 x 106 total ce lls/cul t ure). A stock solu tion of Ro-20-1724 was 
prepa red and frozen in Ro 20- 1724. The solu t ion was ste rilized by 
filtration through 0.45- ,um filte rs. The ce ll . uspens ionR were incubated 
with or without Ro 20-1724 (provided by Hoffm an-LaRoche, Nutley, 
New J ersey ) at final concent rations of 10- 6 M, 10-" M, 10- 4 Min serum -
free RPM! for 1 h at 37•c in a humidified 5% C02- 95% air incubator. 
After incubat ion, t he ce lls were washed and ce ll suspensions were 
reconstituted with RPM! 1640 supplemented with 10% FCS, 2 mM 
f: lu tamine, and antibiotics and incubated at 37•c as described above. 
Separation of S ubpoptdations 
In ini t ial experiments, unfractionated MN L were used. However, in 
furthe r experiments, we used a modified "panning" method to fraction-
a te MNL subsets [1 5- 19] . These populations were sorted into subset-
depleted and -enriched populations by a modification of the panning 
method. The major modification was t he sorting of subsets from 
unfrac t.i onat.ed MNL rather t han from E rosette-puri!iecl T ce lls. This 
a llowed direc t compa ri sons of JgE synthesis by marker-depleted MNL 
whi le retaining similar purity to that achieved with prior E rosetting 
[19]. Purified mouse monoclonal ant ibody (Lyt 3, New England Nu-
clear), against the human sheep erythrocyte recepto r ant igen, was used 
to purify Lyt 3-positive and Lyt 3- negative leukocytes. Simila rly, OKT, 
helper/ inducer ant ibody and OKTs suppressor/ cytotoxic ant ibody (Or-
tho Diagnostics) and an an timonocyte (Mo) antibody (provided by Dr. 
M. Kamoun ) were used to sepa rate T -cell subse ts and monocytes. For 
cont rols, MNL were sensitized with mouse ascites fluid (Bethesda 
Research Labs, Bethesda, Maryland) in place of monoclonal antibody. 
In brief, MN L were sens it ized wi th t he appropriate dilution of antibody 
for 30 min, washed, and added to a polystyrene Petri dish coated with 
goat anti mouse lgE. The plates were incubated at 4 · c for 40 min , 
swirled, and incubated for another 30 min . Marker-depleted ce lls were 
ha rvested as t he nonadherent fraction and the marker-enriched cells 
were harvested from the adherent fraction by vigorous pipetting. The 
nonadherent, marker-negative cell s were t hen added to a freshly coated 
plate for better purity. Marker-negative cells had fewer than 5% posi-
tive cells (i.e., greater than 95 % pure) whereas T ce ll marker-positive 
ce lls were greater than 85% marker pos itive (i .e., 85% pure) as deter-
mined by fluoresceinated goat anti mouse l gG staining. Fewer than 2% 
B cells were present in the positively se lected populations. Monocyte-
depleted cells were 88% pure and monocyte-enriched cells were 67% 
pure as determined by latex ingestion. Ro 20- 1724 at varying concen-
t rations of medium alone was t hen added to eit her the marker-negative 
or marker-posit ive population for 1 h at 37•c in a humidified 5% C0 2 
atmosphere. The ce lls were washed and the treated subpopulation 
combined with the un t reated reciprocal population and cul tured for 10 
days. The cell subset number per culture was that derived from 2.5 X 
lOH MNL sensitized with monoclonal antibody prior to panning. After 
10 days, t he ce lls were freeze-thawed 5 times, cultured 3 more days, 
spun at 500 g for 10 min, and the supernatant frozen for l gE determi-
nation. Puri ty of the cell subpopulations was monitored by indirect 
immunofluorescence, latex ingestion, and surface immunoglobulin de-
termination as previously described [20] . 
IgE Radioimmunoassay 
The quantitative radioimmunoassay for lgE was performed using 
polyvinyl 96-well microliter plates [9] . For measurement of lgE pro-
duction in vitro, microliter plate wells were filled with 300 ,ul 1:100 
goat antihuman lgE (Meloy, Springfield, Virginia) . After incubation in 
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a humidified chamber at 23•c overnigh t, t he coating antibody solution 
was removed and saved for reuse. The wells were washed individually 
3 times wit h 1% bovine serum albumin (BSA) in 0.01 M phosphate-
buffe red sa line (PBS) , pH 7.4 , and 5% BSA in PBS was added to t he 
wells for 1 h. After another wash with 4% BSA in PBS, 250 ,ul of 
sa mples to be assayed were added to we lls and incubated overnight in 
a humidified chamber at 23·c. The following day t he samples were 
removed and disca rded. After 3 washes with 1% BSA in PBS, 250 1d of 
monospecific a ffinity-purified 1251-labeled goat antihuman lgE (Tago, 
Bu rlingame, Cali forn ia) was added to each we ll and incubated overn ight 
in a humidified chamber at 23 · c. ' rhe following day the plates were 
washed 3 times with 1% BSA in PBS and 7 t.imes in running tap wate r. 
The individua l we lls were cut apart and the bound radioactivity was 
determined on a Beckman Gamma 4000 Coun te r (Irvine, California). 
For each radioimmunoassay, a 9-poin t standard curve of lgE (Phadebas 
Reference Serum, Pharmacia, Uppsala, Sweden) was performed in 
pa ra llel with the culture samples. 
For preparing 1251-labeled goat antihuman lgE, 0.2 ml goal antihu-
man lgE was added into 0.5 ml PBS and concentrated to 0. 10- 0.15 ml 
in a collodian bag (Schleicher and Schuell , Keene, New Hampshire) 
through vacuum aspiration . Concent rated antibody was removed to a 
capped via l (4 ml) and then 10 11! chloramine T (10 mg/m l) and 5 ,ul 
'"'!-labeled solution (1 mCi/10 ,ul , New England Nuclear) were added 
and fully mixed with a metal stirring rod on a magnetic stirrer. T en 
minutes late r, 12 ,ul sodium metabisulfite ( 10 mg/ ml) in phosphate 
buffer was added to stop the reaction. Non -protein bound iodide was 
removed by dialys is in the cold agai nst 0.01 M PBS, pH 7.4 , with 2 
changes over a 16- to 20- h pe riod. Labeling was performed fresh once 
week ly. 
Phosphodiestera.~e Assay 
Cells 107/ ml in Gey's balanced salt solut ion were homogenized using 
a Polytron PP 10-32 at 4•c and assayed using modification of t he 
procedure of Thompson et a l [21]. The incubation mix ture (0.4 ml) 
conta ined 0.02-250 M cAMP, 20,000 cpm l"HJcA MP, and 0. 2-ml sample 
in 40 mM Tris- HCI buffer (pH 8.0) containing 3.75 mM beta- mercap-
toethanol and 50 mM MgCI,. Afte r incubation (3o· c for 10 min) t he 
reaction was terminated by snap-freezing in ethanol/dry ice and the 
mixture was boiled for 1 min . Purified 5' -nucleotidase (0.45 units ) was 
added to mix tures which were incuba ted at 30•c for 10 min, then 
transferred to Pasteur pipette columns containing AG1X2 resin and 
counted in Aquasol 2. Enzyme activity was expressed as pmol cAMP 
hydrolyzed per min / 106 cells. Background was less than 5%. 
RESULTS 
Unfra.ctionated MNL Spontaneous In Vitro lgE Production 
T able l demonstrates preformed lgE from MNL from pa-
tients with AD freeze-thawed on day 0 and harvested on day 3 
compared with spontaneously produced total lgE from cells 
freeze-thawed on day 10 and harvested on day 13. The third 
column gives the newly synthesized IgE in these cul tu res (total 
IgE minus preformed IgE) over 10 days. Variation among 
individuals ranged from 562-5419 pg/ml. The correlation of 
serum IgE with newly synthesized lgE was +0.67 (p < 0.05 ). 
TABLE 1. Preformed and newly synthesized spontaneous in uitro JgE 
production" 
Preformed' 
941 
1125 
50 
1681 
50 
190 
2662 
305 
721 
135 
222 
Total' 
2510 
2078 
2482 
5555 
5469 
1032 
4014 
3354 
5228 
697 
2292 
• Expressed as pg/ ml lgE. 
• Freeze- thaw day 0, ha rvest day 3. 
' Freeze thaw day 10, harvest day 13. 
d Total-preformed. 
Newly 
synthesizedd 
1569 
953 
2432 
3874 
5419 
842 
1352 
3049 
4507 
562 
2070 
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For comparison, a ll 10 normal individuals studied produced 
less t ha n 500 pg IgE/ ml. We noted a posit ive correlation of 
n ewly syn thesized IgE in vit ro with serum lgE (r = + 0.67). 
I n h ibition of l n. Vitro lgE Synthesis by Ro 20- 1724 
Fig 1 shows t he effect of treatment with varying concentra-
tions of t he POE inhi bito r Ro 20-1724 on newly synt hesized 
sp ontaneous in vit ro IgE production. P rogressively decreas ing 
a m o un ts of lgE were produced wit h increasing concentrations 
of Ro 20-1724. At 10-6 M, 1520 ± 443 pg/ml were produced; at 
10-5 M, 1317 ± 282 pg/ml were produced; at 10-4 M, 917 ± 198 
pg/ml we re produced. T here was a statistically signifi cant de-
c r ease in lgE synthesis by the 10-5 M-t reated MNL and the 
10-• M-treated MNL, p < 0.05, n = 10 patients. lgE synt hesis 
was inhibited in 9 out of 10 of t hese patients and 10/10 other 
patien ts in whom preformed lgE was not dete rmined (not 
s h own). 
We determined t he corre lation of inhibit ion of lgE synt hesis 
to t h e degree of inhibit ion of P OE activity ac hieved by the 
in hib ito r Ro 20-1724. On day 10, t he MN L cell cul tures from 6 
patients were cent rifuged, t he pellets harvested fo r int racellular 
PDE dete rmination, and t he supernatants analyzed for in vit ro 
IgE production. Fig 2 demonstrates a close relationship between 
t h e degree of P OE inh ibit ion and inhibit ion of lgE production, 
w ith a correlation coefficient of 0.93, p < 0.05. 
T h e viability of cells incubated wi t h Ro 20-1724 was com -
par e d wit h unt reated cells. T rypan blue exclusion showed no 
significa nt cell loss at any of t he Ro 20-1724 concent rations. 
E ffect of RemovaL and Readdition of Untreated MNL Subsets 
on l gE Synthesis 
I n preliminary experiments for t he determination of t he 
leukocyte target of Ro 20-1724 we exp lored the interaction of 
T cells, suppresso r/cytotoxic T cells, helper/ inducer T ce lls, 
a n d monocytes wit h t he lgE producing B cells. 
F ig 3 shows lgE synt hesis in pg/ml by unfractionated cont rol 
MNL , MNL depleted of leukocyte subsets by panning and 
subset marker-depleted MNL recombined wi t h t he reciprocal 
mar ker-enriched subset. IgE synt hesized by MNL sensit ized 
with mouse ascites fl uid and subjected to t he pann i:1g procedure 
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F I G 1. E ffect of Ro 20- 1724 on spontaneous in vit ro lgE synthesis 
by MN L from 10 patients with atopic dermatit is. Inhibition of lgE 
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FIG 3. E ffect of un t reated subset dep letion and recombination on 
spontaneous in vit ro lgE synt hesis. Ba.rs are denoted as marker depleted 
MNL (e.g., Lyt 3-) or marker-depleted MNL recombined with marker-
enriched ce lls (e.g., Lyt 3- and Lyt 3+). T he asterisk indicates significant 
reduction in lgE synthesis: p < 0.01, n = 7. 
was not statistically diffe rent from control MNL (p > .05, n = 
6) . ~emoval by panning of OKT8-sensit ized a nd antimonocyte 
ant ibody-sensit ized MNL did not resul t in a sign ificant alter-
ation of IgE synthesis. By contrast, Lyt 3 (pan T)-depleted 
MNL showed somewhat reduced lgE synt hesis as compared to 
cont rols (n = 9 pairs) (p < 0.10). More specifically, depletion 
of OKT4+ helper/inducer T cells resulted in reduced lgE syn-
theSIS as compared to cont rols. Recombinance of Lyt 3+ cells 
or OKT4+ cell s wit h the subset-depleted MNL restored Io-E 
synthesis to levels not statistically significant fro m controls. 
Thus, spontaneous in vit ro lgE synthesis by AD B cells was 
not suppressible by autologous OKT8-posit ive cells or mono-
cytes, but was part ia lly dependent upon helper effects of the 
OKT4 + subset. 
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Ro 20-1724 Pretreatment of Marker-Enriched and Marker-
Depleted Cells 
To determine t he cellular target of t he drug, subsets of MNL 
pu ri fied by panning were incubated at 37•c for 1 h in a 
humidified C02 incubator with or without 10-" M or 10-• M Ro 
20-1724 in serum-free RPMI. 
The t reated subsets were washed 3 t imes prior to recombi-
nation with t he reciprocal subset a nd cult ure for l gE produc-
tion. Resu lts were expressed as % change from un t reated iden-
t ica l subset recombinations. 
Using the Lyt 3 pan T-cell ant ibody, Lyt 3+ (T-enriched) 
and Lyt 3- (T-depleted) ce lls were prepared. As seen in Fig 4, 
although pretreatment of Lyt 3+ cell s resulted in some inhibi-
t ion of lgE synt hesis by untreated Lyt 3- cell s, pretreatment of 
Lyt 3- cells resul ted in signifi cantly more inhibit ion of lgE 
synthesis. At 10-r. M Ro 20-1724, pretreatment of Lyt 3+ cells 
resu lted in a 16 ± 2% decrease vs a 39 ± 16% decrease when 
Lyt 3- cells were pretreated, n = 8 pairs, p < 0.05. At 10-• M , 
pretreatment of Lyt 3+ cells resulted in a 25 ± 11.4 % decrease 
vs a 52 ± 10.3% decrease when Lyt 3- cell s we re pretreated, n 
= 8, p < 0.05. T hus, cAMP PDE pretreatment of the Lyt 3-
populat ion, composed primarily of B ce lls and monocytes, 
resu lted in significantly more inhibit ion of lgE synthesis t han 
did pretreatment of the T cell-enriched Lyt 3+ population. 
To investigate whether Ro 20-1724 inhibition of l gE synt he-
s is by t he Lyt 3-, B cell- monocyte mixture was due to activation 
of monocyte suppressive influences, a monoclonal ant ibody 
specific for a determinant found on human peripheral blood 
monocyte and myeloid cells was used to purify adherent mon-
ocyte-enriched and nonadherent monocyte-depleted cells. 
T here was no effect (in % change from untreated contro l cells) 
of 10-• M Ro 20-1724 pretreatment of purified monocytes prior 
to recombination with unt reated monocyte-depleted ce ll s (7 ± 
13% increase). In contrast, monocyte-depleted cell pretreat-
ment resu lted in marked inhibition of lgE synt hesis (71 ± 13% 
decrease, p < 0.01, n = 6) of similar degree as t hat seen with T 
depleted cells (48 ± 32% decrease) and unfractionated MNL 
(54 ± 8% decrease). Thus, Ro 20-1724 did not inhibit lgE 
synthesis through stimulation of suppressive monocytes and 
the fu ll effect was achieved in the abse nce of monocytes, 
presumably t hrough a direct effect on B cells. 
Since lgE synthesis was partially dependent on OKT4+ ce lls 
(F ig 3) and a 29% decrease in IgE synt hesis was observed when 
Lyt 3+ cells were pretreated with Ro 20-1724 (Fig 4), we 
examined whether the degree of inhibition seen with Lyt 3+ 
pretreated ce ll s was statistically signi ficant. In orde r to use t he 
0 
-75 
0 10-!! 10-4 
Concentration of Ro 20 -1724 (M) 
FIG 4. Ro 20-1724 (10-5 and 10- ' M) pretreatment of T -enriched 
(Lyt 3+) cells (closed cir cle.5) prior to recombination wit h untreated T -
depleted (Lyt 3- ) ce ll s and in vitro cult ure for spontaneous lgE synthe-
sis as compared to pretreatment ofT-depleted (Lyt 3-) cells (open 
circles) prior to recombination and cul ture. Results a re expressed as % 
cha nge in lgE synthesis from the unt reated identical subset recombi-
nat ion (Lyt. :)+ plus Lyt 3-). n = 6. 
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FIG 5. Ro 20-1724 (1o-• M) pretreatment of positively se lected sub-
sets [Lyt 3+, OKT4+, OKTS+, a nt imonocyte+ (Mo+) ] prior to recom-
bination with the reciproca l subset-depleted MNL and in vitro cult ure 
for spontaneous lgE sy nthesis. n = 6. Only pretreatment of Lyt 3+ (T-
en riched) ce ll s resu lted in a significant cha nge in lgE synt hesis (aster-
ish). 
untreated control cells as an experimental group to compare to 
the pretreated cells, t he data were expressed as % cha nge from 
untreated MNL lgE synthesis. Untreated Lyt 3+ cells recom-
bined wit h Lyt 3-depleted MNL showed a minimal 17 ± 14% 
decrease in l gE synt hesis, whereas 10_,, Ro 20-1724-pretreated 
Lyt 3+ cell s recombined with Lyt 3- showed a 47 ± 11% decrease 
in lgE synthesis, p < 0.001, n = 6. Thus, although not as 
effective as Lyt 3-depleted MNL, Lyt 3+ cells a lso mediate 
inhibition of lgE synt hesis when exposed to Ro 20-1724. 
We further examined t he above T cell-mediated inhibition 
of lgE synthesis to determine whether Ro 20-1724 altered 
helper and suppressor T -ce ll function in t his system. Fig 5 
shows t he effect of 10- • M Ro 20-1724 pretreatment of posit ively 
selected subsets prior to recombination with t he reciprocal lgE-
producing negative subsets (i.e., Lyt 3-, T4- , and T8-). The 
left bar shows t he statistically significant inhibit ion previously 
demonstrated with pretreatment of T3+ cells. However, inhi-
bition was not seen when either T4 + helper T cells or T8+ 
suppressor T cells (n = 6) were pretreated with Ro 20-1724. 
The similar lack of effect with monocytes is shown for compar-
ison. These data suggested t hat, in order to generate T -cell 
inhibition of lgE synthesis by Ro 20-1724, both T4+ and T8+ 
cells must be present together during Ro 20-1724 exposure. 
DISCUSSION 
These investigations have focused on a possible point of 
convergence between cyclic nucleotide regulatory a nd immu-
nologic regulatory defects in AD. The cyclic nucleotide regula-
tory defects at present seem to center on t he marked elevations 
of cAMP PDE activity in MNL from patients with AD [5). 
This elevation is most likely responsible for the reduced cAMP 
responsiveness of t hese cells to all cAMP agonists tested [3,4). 
The most obv ious and consistent immunologic regulatory de-
fects in atopy are t he hyperimmunoglobulinemia E [6) and t he 
elevated spontaneous in vitro lgE synt hesis by B cell s from 
patients with AD [8,13). The cent ral findin g reported here, t hat 
reduction of cAMP PDE with Ro 20-1724 in AD MNL resul ts 
in normalization of IgE product ion by AD MNL, suggests that 
cyclic nucleotide and immunologic defects in AD are linked 
events. 
Ro 20-1724 is an imidazolidinone derivative with inhibitory 
action specific for cAMP PDE. We have found the drug to be 
10- to 100-fold more potent than theophylline and 10-fold less 
potent t han isobutylmethylxanthine in our system. In the same 
study, we showed t hat t he high activity PDE in MNL from 
patients with AD is much more sensit ive to PDE inhibitors 
than PDE from normals [22). 
We have previously provided evidence that elevated cAMP 
PDE in AD resulted in reduced cAMP levels in response to all 
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cAMP elevating agents tested (histamine, catecholamines, and 
PGE1) (3,5). As shown by Goldstein and coworkers, t he t hym ic 
hormone thymopoietin mediates its inductive effect on T -cell 
differentiation through cAMP elevation [23,24). Abnormally 
differentiated T cell s may be involved in elevated IgE produc-
tion in AD. Simila rly, t hymic hormones have inhibitory influ-
ences on early B-cell differetiation [24-26], which may a lso be 
cyclic nucleotide mediated [24). Thus, differentiative signals, 
normally mediated through cAMP, which promote T-cell dif-
ferentiation or inhibi t B-cell differentiation would not be deliv-
ered to t he interior of the cell in AD. Correction of t he abnormal 
PDE in AD cells may have a llowed normalization of cAMP 
responsiveness to regulatory influences by other cells with 
resultant inhibition of spontaneous IgE synt hesis. 
Our prior findings of reduced numbers of beta-adrenergic 
receptors, reduced cAMP responses, and extremely high PDE 
levels in purified B cells suggested t hat B cells a re norma lly 
protected from cAMP elevations and t hat the~ ~i~ht be par-
ticu larly sensitive to direct inhibition by PDE mhibi tors [27]. 
We t herefore performed experiments to determine which 
MNL subpopu lations were mediating t he inhibition of IgE 
synthesis induced by Ro 20-1724. There was sign ificantly more 
inhibition when T cell-depleted MNL (B cell - and monocyte-
enriched) were pretreated with Ro 20-1724 than when T-
enriched cell s were pretreated (Fig 4). We examined whether 
the effect on T cell -depleted MNL cells was mediated through 
activation of suppressive monocytes or directly t hrough B cells. 
Monocyte-depleted MNL ce lls pretreated with Ro 20-1724 a lso 
were sign ificantly more inhibited than pretreated monocyte-
enriched ce ll s. Thus, t he majority of t he effect was mediated 
through a non-T, nonmonocyte target, presumably t hrough a 
direct effect on the IgE producing B cells. An effect on null 
cells is a remote possibility. The lack of inhibi tion seen with 
pretreated monocytes a lso rules aga inst t he possibility t hat 
inhibition seen with pretreated T cells was due to carryover of 
low concentrations of Ro 20-1724 to the sensitive B cells in t he 
Lyt 3- population. . . 
This type of direct in tervention with B-cell functiOn could 
be expected based on t he preactivated, terminally differentiated 
nature of the spontaneous IgE producing B cells involved 
[8,9,11), and on t he high levels of cAMP PDE which B cel ls 
maintain [27). Simila r direct inhibi tio n of antigen-spec ific hu -
man B cell IgE production has been ac hieved through ant igen-
induced unresponsiveness of the specific IgE producing B ce lls 
[13,28]. . ... 
We also observed a signifi cant degree of mhibi tiOn when Lyt 
3+ cells were pretreated with Ro 20-1724. Since in vitro IgE 
synthesis was partially dependent on OKT4+ helper ce ll inllu-
ences (Fig 3) [1 4], but unregulated by OKT8+ suppressor ce ll s 
(Fig 3 ), inhibition of these OKT4 + helper cell influences by Ro 
20-1724 seemed most likely. When purified OKT4+ and OKT8+ 
subsets were pretreated, no statistically signi ficant changes in 
IgE synt hesis were seen (Fig 5), a lt hough t he trend t_ends to 
support t he above view. Full T-cell inhibi tion may reqUire both 
the OKT4 helper a nd t he OKT8 suppressor/cytotox ic cells to 
be present during t he Ro 20-1724 pretreatment. This suggests 
that some interaction between OKT4 and OKTS cells may have 
occurred in the presence of Ro 20-1724, resulting in either 
enhanced suppressor or reduced helper function. An addit ional 
possibili ty is that Ro 20-1724 effects on T cell s are ~xpressed 
only during the latter phase of t he 10-day culture penod when 
T cell helper function for lgE synthes is (late) may be more 
prominent. Conceivably, PDE inhibi tion ofT cells at a later 
time in the cult ure may show more dramatic effects. 
Using adherence methods, Romanagni et al [11) and Hsieh 
[29] examined t he effect of monocyte depletion on lgE synthe-
sis. Hsieh found that removal of adherent cells reduced lgE 
synthesis, but the study did not control for nonspecific loss of 
B cell s during adherence. Preliminary experiments to examine 
the role of monocyte suppressive influences showed that deple-
tion of monocytes by adherence to t issue culture fl asks resulted 
in reduction of IgE production. This was in large part due to 
nonspecific loss of surface immunoglobulin (Slg+) cells in plas-
t ic t issue culture flasks which occurred to a greater degree than 
in t he Petri dishes used in panning. Reduced lgE production 
by MNL depleted of monocytes by adherence was not due to a 
change in IgE production per B cell (unpublished observations). 
Romagnani et a! [11) a lso observed this decrease of lgE in 
MNL depleted of adherent monocytes but showed evidence 
that the reduction was in la rge part accountable by loss of 
preformed TgE, consistent with our above interpretation. 
With non-IgE in vit ro immunoglobul in production assays, 
the role of agents that a lter cyclic nucleotides in the modulation 
of immunoglobulin production is unclear [30). However, some 
investigators have been able to demonstrate t hat isoproterenol 
induced inhibi t ion of immunoglobu lin -secreting cells and t hat 
t his effect was mediated through suppressor T -cell induction 
[30]. Since MNL from normal individuals and patients with 
AD spontaneously produce only minimal amounts of lgG, IgA, 
and IgM in vitro [20], t he effects of Ro 20-1724 on spontaneous 
production of t hese a llotypes remain to be investigated. 
Despite t he very low levels of IgG production in t hese un-
stimulated cul tures, it is conce ivable that part of the cha nges 
in total IgE synt hesis observed here may be due to changes in 
idiotype contained within IgG, and for which the anti-IgE 
carries anti- idiotypic activity. However, t he use of 2 independ-
ent ly generated anti- IgE ant ibodies reduces t he likelihood of 
detecting common idiotypes in the radioimmune assay. 
In conclusion, inhibition of the elevated cAMP PDE in MNL 
from patients with AD resulted in a closely related reduction 
in lgE synthesis by spontaneously producing B cells in vitro. 
The effect was predominantly mediated directly on B cells, but 
some inhibition was mediated indirectly through T cells as well. 
PDE inhibitors may provide an exciting new investigational 
probe and t herapeutic tool in AD and allow us to firmly link 
the cycl ic nucleotide and immunologic abnormalities in the 
disease. 
The authors express their thanks to Lynn-Marie Dixon and Barbara 
Winters fo r their assistance in preparation of this manuscript. 
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